1 minute reading time (27 words)

‘Impressed with Impact' of Ketamine in Cancer Palliative Care

Toronto psychiatrist Madeline Li, MD, PhD, is running the only registered study to investigate ketamine specifically for the treatment of depression in cancer patients. 

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More